Lifeward Reports Third Quarter 2026 Financial Results and Provides Business UpdateGlobeNewsWire • 11/13/26
Lifeward's ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed StudyGlobeNewsWire • 10/14/26
Peer-Reviewed Study of Lifeward's ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and PainGlobeNewsWire • 09/15/26
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth StrategyGlobeNewsWire • 09/08/26
Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial OfficerGlobeNewsWire • 08/31/26
Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives GrowthGlobeNewsWire • 08/14/26
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal ExoskeletonGlobeNewsWire • 08/05/26
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic FinancingGlobeNewsWire • 07/07/26
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed PlatformGlobeNewsWire • 05/19/26
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered ExoskeletonGlobeNewsWire • 05/04/26
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical CompanyGlobeNewsWire • 03/13/26
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026GlobeNewsWire • 03/10/26
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal ExoskeletonGlobeNewsWire • 03/02/26
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke SurvivorsGlobeNewsWire • 02/25/26